Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

NHS Blood and Transplant

Easier access to medicines in the UK?

Cutting through the NICE value-based assessment consultation to find out what’s at stake

- PMLiVE

Omega buys pharmacy to understand customers

Will turn Warman-Freed in North London into ‘learning pharmacy’

- PMLiVE

NICE backs Gilead’s Sovaldi in hepatitis C

But health watchdog denies earlier use of Janssen’s Zytiga

- PMLiVE

UK pharmacies can play bigger public health role

Report says pharmacies should extend range of services for communities

- PMLiVE

Community pharmacies central to diabetes fight in UK

Risk assessments can help identify people at risk of developing condition

National Institute for Health and Care Excellence NICE logo

NICE confirms wider statin use

Reduces threshold for risk of heart disease

UK flag

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities

- PMLiVE

NICE backs Lundbeck’s alcohol dependence drug Selincro

Alcoholics in England to have access to once-daily drug

- PMLiVE

SMC decides Celgene’s Imnovid is not cost-effective

Scottish cancer patients denied access to the cancer drug

- PMLiVE

UK NHS needs to rethink long-term care

MPs call for system change as chronic conditions account for 70 per cent of yearly healthcare spend

- PMLiVE

New NHS CEO announces senior changes

Simon Stevens strengthens leadership within NHS England

UK flag

UK healthcare professionals urged to say ‘no’ to antibiotics

Royal Colleges issues joint statement to members warning of antimicrobial resistance

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links